Business Wire

Fulgent Genetics Awarded Contract by the U.S. Department of Veterans Affairs to Provide Hereditary Cancer, Pharmacogenetic and Other Genetic Testing to Veterans

EL MONTE, Calif.--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent,” or the “Company”), a technology-based company with a well-established laboratory services business and a ...
Medscape

Pharmacogenetics: From Discovery to Patient Care

Purpose: The basic concepts of pharmacogenetics, pharmacogenetic study approaches, factors to consider when applying pharmacogenetic discoveries to patient care, and potential roles for pharmacists in ...
Medscape

Patients' and Healthcare Professionals' Views on Pharmacogenetic Testing and Its Future Delivery in the NHS

This study explored patients' and healthcare professionals' views and knowledge of pharmacogenetic testing and associated future service development. Patients and healthcare professionals discussed ...
Nasdaq

Genedrive PLC Advances in Pharmacogenetic Testing Innovation

Genedrive (GB:GDR) has released an update. Genedrive PLC, a leader in pharmacogenetic testing, continues to innovate with its Genedrive® MT-RNR1 ID Kit and CYP2C19 ID Kit, enhancing personalized ...
Business Wire

Genomind Launches First-of-Its-Kind Patient Report: Offering Patients an Easy-to-Understand View into Personalized Genetic Test Results

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Genomind, a leader in medication management and personalized medicine through pharmacogenetics (PGx), is proud to announce the release of its innovative Patient ...
EurekAlert!

New UK guideline for clopidogrel recommends pharmacogenetic testing for all patients before prescription

The UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (UK CERSI-PGx), led by the University of Liverpool, has published its first clinical guideline focused on the use ...